Back to company

Boehringer Ingelheim Animal Health Denmark A/S: Financial statements 2017

CVR: 13526990

Boehringer Ingelheim Animal Health Denmark A/S (CVR 13526990) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 615,004,000 and a net result of DKK 628,833,000 compared with DKK 3,876,000 the year before. The profit margin was 102.2%. Equity amounted to DKK 687,459,000. The solvency ratio was 86.5%. The company had 31 employees in the financial year.

Revenue
615,004,000 kr.
Gross Profit
923,046,000 kr.
Profit/Loss
628,833,000 kr.
Equity
687,459,000 kr.
Total Assets
794,596,000 kr.
Employees
31

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2017615 mio.923 mio.628.8 mio.687.5 mio.31
2016-39 mio.3.9 mio.27.6 mio.31
2015--3.7 mio.23.7 mio.35
2014-67.2 mio.5.8 mio.20 mio.29
2013-67.1 mio.6.4 mio.20.2 mio.29

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like Boehringer Ingelheim Animal Health Denmark A/S

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2017

Boehringer Ingelheim Animal Health Denmark A/S appoints new auditorSep 25, 2017

As of September 25, 2017, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Boehringer Ingelheim Animal Health Denmark A/S.

Auditor steps down at Boehringer Ingelheim Animal Health Denmark A/SSep 25, 2017

As of September 25, 2017, EY Godkendt Revisionspartnerselskab has stepped down as auditor of Boehringer Ingelheim Animal Health Denmark A/S.

Boehringer Ingelheim Animal Health Denmark A/S: The 2016 annual report is outJun 9, 2017

Boehringer Ingelheim Animal Health Denmark A/S has published its annual report for 2016. Gross profit came to DKK 39,000,000, and the net result was DKK 3,876,000.

Jesper Peulicke joins the board of Boehringer Ingelheim Animal Health Denmark A/SApr 30, 2017

As of April 30, 2017, Jesper Peulicke has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.

Nedim Pipic joins the board of Boehringer Ingelheim Animal Health Denmark A/SApr 30, 2017

As of April 30, 2017, Nedim Pipic has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.

Pierluigi Crippa leaves the board of Boehringer Ingelheim Animal Health Denmark A/SApr 30, 2017

As of April 30, 2017, Pierluigi Crippa has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.

Nedim Pipic leaves the board of Boehringer Ingelheim Animal Health Denmark A/SApr 29, 2017

As of April 29, 2017, Nedim Pipic has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.

Niels Berenth From joins the board of Boehringer Ingelheim Animal Health Denmark A/SMar 31, 2017

As of March 31, 2017, Niels Berenth From has joined the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.

Niels Berenth From joins Boehringer Ingelheim Animal Health Denmark A/S as adm. dir.Mar 31, 2017

As of March 31, 2017, Niels Berenth From is registered as adm. dir. of Boehringer Ingelheim Animal Health Denmark A/S.

Karsien Elzo ten Have leaves the board of Boehringer Ingelheim Animal Health Denmark A/SMar 6, 2017

As of March 6, 2017, Karsien Elzo ten Have has left the board of directors of Boehringer Ingelheim Animal Health Denmark A/S.

About Boehringer Ingelheim Animal Health Denmark A/S

Boehringer Ingelheim Animal Health Denmark A/S is a Danish company of the type Aktieselskab based in København S, founded in 1989. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named MERIAL NORDEN A/S and RHONE MERIEUX NORDEN A/S. The management consists of Dirk Neven Rauleder. The company is owned by Boehringer Ingelheim Animal Health International GmbH. The company has 95 employees. In 2025, the company reported revenue of DKK 725,936,000 and a net result of DKK -3,950,000 compared with DKK 40,407,000 the year before. Equity amounted to DKK 90,111,000.